Pluristem Therapeutics (NasdaqCM: PSTI; TASE: PLTR) is Profiled in this Database

Updated At 19 Dec, 2011

Partial description of this company

Drug delivery platform that releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory and ischemic diseases

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Pluristem Therapeutics (NasdaqCM: PSTI; TASE: PLTR) plus 4814 other startups.

Start Free 7 Day Trial Now

Learn More About Pluristem Therapeutics (NasdaqCM: PSTI; TASE: PLTR)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation